Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00542685 · ClinicalTrials.gov registry record · Phase 3
A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 551
- Enrollment target
NCT00542685 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 551 participants.
The verdict
NCT00542685, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 551 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of PD 0332334 for the treatment of generalized anxiety disorder.
Interventions
- DRUG Placebo
- DRUG PD 0332334
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00542685
The ClinicalTrials.gov registry entry for NCT00542685 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 551 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00542685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00542685 about?
NCT00542685 is a clinical study titled "A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder". This study will evaluate the efficacy and safety of PD 0332334 for the treatment of generalized anxiety disorder.
What is the current status of trial NCT00542685?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 551 participants. The study started on 2007-10. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00542685?
The interventions under investigation include: Placebo (DRUG), PD 0332334 (DRUG).
Who is sponsoring clinical trial NCT00542685?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.